List of SBIR/STTR awards granted to TherapyX
TherapyXA SBIR Phase II contract was awarded to TherapyX in May, 2020 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to TherapyX in July, 2020 for $807,210.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to TherapyX in July, 2018 for $320,159.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to TherapyX in August, 2019 for $239,162.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to TherapyX in March, 2020 for $858,320.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to TherapyX in March, 2019 for $388,880.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to TherapyX in February, 2022 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase II contract was awarded to TherapyX in February, 2017 for $1,793,879.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX in September, 2016 for $295,831.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to TherapyX in June, 2017 for $2,999,994.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to TherapyX in June, 2014 for $1,498,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX in January, 2015 for $271,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX for $158,517.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX for $172,500.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX for $292,501.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to TherapyX for $2,555,134.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX for $300,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to TherapyX for $2,999,994.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to TherapyX for $144,961.0 USD from the U.S. Department of Health & Human Services.
